What gives you reason to believe that ANTH's lupus drug looks like a better version of HGSI's Benlysta? Is this based on specific trial data that has looked better than Benlysta or is this based on MoA of ANTH's drug theoretically being superior in some way?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.